{"Exaggerate": "The claim exaggerates the effectiveness and approval status of remdesivir as a COVID-19 treatment.", "Falters at times": "The claim falters by not accurately representing the FDA's statements about remdesivir.", "Lack enough support": "The claim lacks enough support as the FDA has not approved remdesivir as a treatment for COVID-19.", "Problematic assumption": "The claim assumes that the FDA's emergency use authorization is equivalent to full approval, which is a problematic assumption.", "Exist alternative explanation": "There is an alternative explanation that remdesivir is still being studied and has not been proven to be safe and effective for treating COVID-19."}